UBS Group’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

UBS Group’s Portfolio SENT Stock Details SENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-76	Closed	-$1.69K	–	10498
2023 Q3	$1.69K	Buy	+76	New	+$1.79K	﹤0.01%	7853
2023 Q1	–	Sell	-480	Closed	-$10.8K	–	11007
2022 Q4	$10.8K	Buy	480 +416	+650%	+$9.56K	﹤0.01%	8468
2022 Q3	$1K	Sell	64 -16	-20%	-$352	﹤0.01%	10151
2022 Q2	$2K	Sell	80 -124	-61%	-$2.77K	﹤0.01%	9694
2022 Q1	$5K	Buy	+204	New	+$5.03K	﹤0.01%	9207
2021 Q4	–	Sell	-25	Closed	-$1K	–	10971
2021 Q3	$1K	Buy	+25	New	+$685	﹤0.01%	9325

UBS Group's SENT Position: Q4 2023 in Review

UBS Group sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q4 2023, closing a stake of 76 shares — an estimated $1.69K sold.

UBS Group first reported a position in SENT in Q3 2021 and held it in 6 quarters. The position peaked at $10.8K in Q4 2022. 0 funds tracked by Wall St. Rank hold SENT as of Q4 2023.

UBS Group reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q4 2023 after selling out during the quarter.
UBS Group sold 76 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q4 2023, an estimated $1.69K.
UBS Group first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q3 2021 and held it in 6 quarters.
UBS Group's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $10.8K in Q4 2022.
0 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.